Skip to main content

COVID-19 Vaccine Information

Build Immunity in the Community: upload your vaccine record

Students, faculty and staff are challenged to come together to Build Immunity in Our Community, with a goal to have 70% of the campus community vaccinated by July 1. If we reach this goal, the level of immunity in our campus community will enable the Path Forward team to ease some restrictions and requirements depending on the state of the pandemic.

After you complete your vaccination, upload a photo of your vaccine record today to the confidential "Report your Vaccine" portal. If you have not yet received your vaccine, schedule an appointment so you can report your vaccination by July 1. Starting June 1, we will begin reporting the campus community's progress toward the goal here. We will report back to the community in July how the vaccination rate will shape the fall semester, and whether our approach will need to change. Your vaccination record only will be accessible by medical providers and contact tracers, and not tied to any employment or academic records.

View frequently asked questions about the COVID-19 vaccine on this page. Click here for the recording of the town hall meeting about vaccines with members of UD's medical panel.

Obtaining a Vaccine

Individuals 16 and older in the state of Ohio, including those attending an Ohio college or university, can receive the vaccine. College students should use their student ID as proof of eligibility. The approved ages for each vaccine are:

  • Pfizer: ages 16 and older
  • Moderna: ages 18 and older
  • Janssen by Johnson & Johnson: ages 18 and older

Vaccine FAQs

In phase 3 clinical trials, the Pfizer-BioNTech vaccine was 95% effective against contracting symptomatic COVID-19. The Moderna vaccine was 94% effective against contracting symptomatic COVID-19. The Johnson & Johnson Janssen vaccine was 85% effective against contracting symptomatic COVID-19.

All vaccines have proven to be close to 100% effective in preventing severe illness and death attributable to COVID-19.

Learn More about How COVID-19 Vaccines Work (CDC)

So far, studies suggest that antibodies generated through vaccination with currently authorized vaccines recognize these variants. This is being closely investigated and more studies are underway.

Rigorous and increased compliance with public health mitigation strategies, such as vaccination, physical distancing, use of masks, hand hygiene, and isolation and quarantine, is essential to limit the spread of the virus that causes COVID-19 and protect public health.

Information about the characteristics of these variants is rapidly emerging. Scientists are working to learn more about how easily they spread, whether they could cause more severe illness, and whether currently authorized vaccines will protect people against them.

Viruses constantly change through mutation, and new variants of a virus are expected to occur over time. Sometimes new variants emerge and disappear. Other times, new variants emerge and persist. Multiple variants of the virus that causes COVID-19 have been documented in the United States and globally during this pandemic.

These variants seem to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. An increase in the number of cases will put more strain on health care resources, lead to more hospitalizations, and potentially more deaths. 

Anyone who has not yet been vaccinated against COVID-19 is at significant risk of infection with new variants, and allows the virus to continue to mutate and create more problematic variants. All are strongly encouraged to be fully vaccinated to protect themselves, their loved ones, and vulnerable others from current variants and to prevent future variants.

Read more from the Centers for Disease Control and Prevention here

Read about COVID-19 Vaccine Effectiveness Research here

CDC vaccination data tracker

In speaking about the Moderna and Pfizer COVID-19 vaccines, Pope Francis said: "I believe that ethically everyone must take the vaccine. It is not an option; it is an ethical action, because you are playing with your health, you are playing with your life, but you are also playing with the lives of others." The Vatican's doctrinal office also has said it is morally acceptable for Catholics to take the vaccines.

Additional guidance comes from the U.S. Conference of Catholic Bishops, which has stated that receiving the COVID-19 vaccine "ought to be understood as an act of charity toward the other members of our community. In this way, being vaccinated safely against COVID-19 should be considered an act of love of our neighbor and part of our moral responsibility for the common good."

Additionally, the U.S. Conference of Catholic Bishops provide additional guidance regarding the Johnson & Johnson vaccine here: U.S. Bishop Chairmen for Doctrine and for Pro-Life Address the Use of the Johnson & Johnson Covid-19 Vaccine.

Catholic Cares, a coalition of U.S. Catholic organizations encourages the public to get vaccinated, provides information about the teachings of Pope Francis and U.S. Catholic Bishops on accepting the vaccine.

None of the emergency use authorized and recommended COVID-19 vaccines or COVID-19 vaccines in development in the United States contains the live virus that causes COVID-19, so a COVID-19 vaccine cannot make you sick with COVID-19.

However, some vaccinations may result in symptoms similar to COVID-19. These symptoms are a result of the vaccine teaching the immune system how to recognize and fight the virus, and are a sign the body is building protection against the virus that causes COVID-19.

It also is possible to be exposed and develop COVID-19 illness shortly after vaccination and before your body develops protective antibodies.  

Learn More About How COVID-19 Vaccines Work (CDC)

You may have mild side effects, including soreness or redness at the injection site. Other common short-term side effects are fever, chills, headache, tiredness and muscle or joint pain. These side effects are normal as your body creates an immune response to protect you from COVID-19, and may increase with the second dose.

Individuals who were infected with COVID-19 may experience some of these symptoms after the first vaccine dose.

It is recommended to drink plenty of water and eat something before your vaccination.

According to the Centers for Disease Control and Prevention, serious side effects that could cause a long-term health problem are extremely unlikely following any vaccination, including COVID-19 vaccination. Vaccine monitoring has historically shown that side effects generally happen within six weeks of receiving a vaccine dose. For this reason, the FDA required each of the authorized COVID-19 vaccines to be studied for at least two months (eight weeks) after the final dose. Millions of people have received COVID-19 vaccines, and no long-term side effects have been detected.

CDC continues to closely monitor the safety of COVID-19 vaccines. If scientists find a connection between a safety issue and a vaccine, FDA and the vaccine manufacturer will work toward an appropriate solution to address the specific safety concern (for example, a problem with a specific lot, a manufacturing issue, or the vaccine itself).

View a Video About What to Expect (CDC)

According to an Ohio Department of Health update July 2, the U.S Centers for Disease Control and Prevention (CDC) continues to recommend COVID-19 vaccination for individuals 12 years of age and older, given the risk of COVID-19 illness and related, possibly severe complications such as long-term health problems, hospitalization and death. 

The American Academy of Pediatrics, the American Academy of Family Physicians, the American Medical Association, the American College of Physicians, the American Heart Association, American Nurses Association and several other organizations have joined the CDC in issuing a joint statement on COVID-19 vaccination and myocarditis/pericarditis

“The facts are clear: this is an extremely rare side effect, and only an exceedingly small number of people will experience it after vaccination. Importantly, for the young people who do, most cases are mild, and individuals recover often on their own or with minimal treatment. In addition, we know that myocarditis and pericarditis are much more common if you get COVID-19, and the risks to the heart from COVID-19 infection can be more severe,” according to the statement.

The U.S. Food & Drug Administration (FDA) has updated COVID-19 Vaccine Emergency Use Authorization fact sheets for the Pfizer and Moderna vaccines for patients and providers to include the risks of myocarditis and pericarditis following vaccination. In addition, the CDC updated for providers its clinical considerations regarding myocarditis and pericarditis. These updates follow a review of information and a discussion by the CDC’s Advisory Committee on Immunization Practices last week. The FDA and CDC will continue to monitor reports, collect more information, and follow up to assess longer-term outcomes over several months.

Since April 2021, there have been more than 1,000 reports of cases of myocarditis and pericarditis after mRNA COVID-19 vaccination (i.e., Pfizer-BioNTech, Moderna) in the United States. However, not all cases have been verified. The CDC is evaluating 484 total reported cases, 323 of which meet the CDC working case definition for myocarditis or pericarditis. All of these cases were among vaccine recipients younger than 30. The CDC notes these reports are rare given the millions of COVID-19 vaccine doses administered.

Read more information from the Centers for Disease Control and Prevention here.

It typically takes a few weeks for the body to build protection against the virus that causes COVID-19 after vaccination. So it is possible someone could be infected with COVID-19 just before or just after vaccination and still get sick with the virus before you are fully immune.

None of the authorized and recommended COVID-19 vaccines cause you to test positive on viral tests, which are used to see if you have a current infection. Neither can any of the COVID-19 vaccines currently in clinical trials in the United States.

If your body develops an immune response to vaccination, which is the goal, you may test positive on some antibody tests. Antibody tests indicate you had a previous infection and that you may have some level of protection against the virus. Experts are currently looking at how COVID-19 vaccination may affect antibody testing results.

Yes, because of the severe health risks associated with COVID-19 and because reinfection with COVID-19 is possible.

Experts are unsure how long someone who had COVID-19 will have natural immunity. They have said the duration of immunity after having COVID-19 is variable and could go away as early as three months. Vaccination boosts and extends that protection, including to new variants identified as of June 2021.

You can read more from the Centers for Disease Control here.

Individuals who are vaccinated will not be subject to entry or surveillance testing, or required to quarantine as a close contact. Because of the uncertainty about the duration of immunity from having COVID, students who are not vaccinated ⏤ even if they have had COVID-19 ⏤ will be subject to both.

Read guidance from the Centers for Disease Control and Prevention here.

According to the CDC, most fully vaccinated people with no COVID-like symptoms do not need to quarantine, be restricted from work, or be tested following an exposure to someone with suspected or confirmed COVID-19, as their risk of infection is low.

Fully vaccinated means two weeks have elapsed after the second dose of a two-dose series, such as the Pfizer or Moderna vaccines, or two weeks after a single-dose vaccine, such as the Johnson & Johnson vaccine.

COVID-19 mRNA vaccines do not change or interact with your DNA in any way.

Learn More About How COVID-19 mRNA Vaccines Work (CDC)

According to the CDC, based on current knowledge, experts believe COVID-19 vaccines are unlikely to pose a risk to a person trying to become pregnant in the short or long term. Furthermore, the CDC adds there is no evidence antibodies formed from COVID-19 vaccination cause any problems with pregnancy, including the development of the placenta. In addition, there is no evidence suggesting fertility problems are a side effect of ANY vaccine. People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine. Pregnant women have a higher risk of complications from being infected with COVID-19, so they are advised to discuss vaccination with their obstetrician.

The CDC also states mRNA vaccines are not thought to be a risk to the breastfeeding infant. People who are breastfeeding and are part of a group recommended to receive a COVID-19 vaccine, such as healthcare personnel, may choose to be vaccinated.

If you are planning to get a screening mammogram soon, you may wish to schedule that with the timing of the second dose of your vaccine in mind. Some experts recommend waiting until six weeks after the second vaccine dose. Consider consulting with your physician for more insight.  

Additional information can be found at the bottom of the CDC's "Myths and Facts about COVID-19 Vaccines" page and the CDC's "Vaccination Considerations for People who are Pregnant or Breastfeeding," plus by consulting with your primary care physician or specialist.

The COVID-19 vaccines available in the United States do not contain eggs, preservatives or latex. For a full list of ingredients, please see each vaccine's fact sheet for recipients and caregivers: 

Yes. Approximately 42% of participants in Pfizer BioNTech's worldwide clinical trials, 37% of the Moderna study population, and 26% of the participants in Johnson & Johnson's study were from minority communities, which is similar to the diversity of the U.S. at large.

In addition, clinical studies included participants age 65 and older (21% of Pfizer-BioNTech participants; 23% of Moderna participants) or 60 and older (34% of Johnson & Johnson participants); and those with high-risk chronic diseases, such as diabetes, severe obesity and cardiac disease (46% of Pfizer-BioNTech participants; 42% of Moderna participants; 41% of Johnson & Johnson participants).

Vaccinated persons who have been exposed to someone with suspected or confirmed COVID-19 are not required to quarantine if they meet all of the following criteria:

  • Are fully vaccinated (i.e., more than 2 weeks following your final dose of a one- or two-dose series).
  • Are within 3 months following receipt of the last dose in the series.
  • Have remained asymptomatic since the current COVID-19 exposure.

Persons who do not meet the above criteria should continue to follow UD quarantine guidance after exposure to someone with suspected or confirmed COVID-19 and must report their close contacts on the University's COVID-19 health reporting page.

View Public Health Recommendations for Vaccinated Persons (CDC)

According to the Centers for Disease Control and Prevention, in addition to providing protection against COVID-19, there is increasing evidence that these mRNA COVID-19 vaccines provide protection against infections that do not result in symptoms. Read more from the CDC here.

According to the Centers for Disease Control and Prevention, you should still protect yourself and others in many situations by wearing a mask that fits snugly against the sides of your face and doesn’t have gaps. Take this precaution whenever you are:

  • In indoor public settings
  • Gathering indoors with unvaccinated people (including children) from more than one other household
  • Visiting indoors with an unvaccinated person who is at increased risk of severe illness or death from COVID-19 or who lives with a person at increased risk
  • You should still avoid indoor large gatherings.
  • If you travel, you should still take steps to protect yourself and others. You will still be required to wear a mask on planes, buses, trains, and other forms of public transportation traveling into, within, or out of the United States, and in U.S. transportation hubs such as airports and stations. Fully vaccinated international travelers arriving in the United States are still required to get tested within 3 days of their flight (or show documentation of recovery from COVID-19 in the past 3 months) and should still get tested 3-5 days after their trip.
  • You should still watch out for symptoms of COVID-19, especially if you’ve been around someone who is sick. If you have symptoms of COVID-19, you should get tested and stay home and away from others.
  • You will still need to follow guidance at your workplace.
  • People who have a condition or are taking medications that weaken the immune system, should talk to their healthcare provider to discuss their activities. They may need to keep taking all precautions to prevent COVID-19.

View Key Things to Know about the COVID-19 Vaccine

UD-Specific FAQs

The University is an enrolled provider and will provide the vaccine when it becomes available to the University from the State of Ohio.

View Ohio's COVID-19 Vaccination Site

Employees should use sick time to get the vaccine, as well as for time taken because of an adverse reaction to the vaccine. Similar to reporting for a COVID-19 illness, report your sick time as you normally would and then contact Beth Schwartz, director of UD's benefits and wellness program, to replenish your charged sick time.

UD employees should use this form to report they've received their full COVID-19 vaccination and upload their vaccination record; this form needs to be completed to replenish your sick time.

Upload your official COVID-19 vaccination card, which includes your full name, date of birth and vaccine details on the confidential "Report Your Vaccine" portal.

If a UD employee requests that Human Resources replenish their sick time, then they must report their full COVID-19 vaccination and upload their record.

The confidential process used for collecting and storing COVID-19 vaccination information is similar to that which all first-year students currently follow to submit their other vaccinations. Your vaccination information will be treated confidentially; it is not tied to employment or academic records.

Once you upload your vaccination record, you should receive a confirmation email from with the subject line "[Confidential] Report of COVID-19 Vaccination Received."

We know everyone is looking forward to a year with more in-person learning, community-building activities and social opportunities. That is why we are issuing the Build Immunity in Our Community Challenge, with a goal to have 70% of the entire campus community vaccinated by July 1. 

If we reach this goal, the level of immunity in our campus community will enable the Path Forward team to ease more restrictions and requirements depending on the state of the pandemic — especially those most important to you.

Fully vaccinated individuals who have reported their vaccination will not be subject to testing on campus nor subject to quarantine requirements.

Fully vaccinated means two weeks have elapsed after the second dose of a two-dose series, such as the Pfizer or Moderna vaccines, or two weeks after a single-dose vaccine, such as the Johnson & Johnson vaccine.

The University strongly encourages everyone on campus to be fully vaccinated. In addition to our commitment to the common good and the need to protect vulnerable populations, the level of vaccination in our campus community will shape COVID-19 protocols for fall semester governing events and activities as well as room capacities and guest policies, among others. 

We know everyone is looking forward to a year with more in-person learning, community-building activities and social opportunities. That is why we are issuing the Build Immunity in Our Community Challenge, with a goal to have 70% of the entire campus community vaccinated by July 1. 

If we reach this goal, the level of immunity in our campus community will enable the Path Forward team to ease more restrictions and requirements depending on the state of the pandemic — especially those most important to you. 

The American College Health Association recognizes that "comprehensive COVID-19 vaccination is the most effective way for institutions of higher education to return to a safe, robust on-campus experience for students in fall semester 2021."  

For more information, visit CDC's COVID-19 vaccine page. To find a vaccine provider: